Efficacy and safety of catheter ablation for atrial fibrillation in very elderly patients: a single-center retrospective cohort study
Abstract Background Catheter ablation is increasingly used for rhythm control in atrial fibrillation (AF), but evidence in very elderly patients remains limited. Methods We retrospectively studied consecutive patients aged ≥65 years undergoing first AF ablation between 2018 and 2022. Effectiveness was evaluated in 457 patients with evaluable post-discharge rhythm follow-up, whereas periprocedural safety was evaluated in all 494 otherwise eligible patients with ascertainable inpatient safety outcomes. Outcomes were compared among patients aged ≥75 years, 70–74 years, and 65–69 years. Radiofrequency ablation (RFCA) and cryoballoon ablation (CBA) were compared descriptively among patients aged ≥75 years. Results Of 457 patients included in the effectiveness analysis, 82 were aged ≥75 years, 123 aged 70–74 years, and 252 aged 65–69 years. The corresponding 12-month Kaplan–Meier estimates of freedom from documented recurrence were 80.72%, 66.77%, and 73.38% (95% CIs 70.04%–87.91%, 57.42%–74.52%, and 67.35%–78.48%, respectively; log-rank P = 0.096). Age group was not associated with documented recurrence in the main adjusted analysis (overall age-group P = 0.152). Among 494 patients in the safety analysis, the composite periprocedural safety endpoint occurred in 7.87%, 3.73%, and 3.69%, respectively (P = 0.240). In the descriptive ≥75-year subgroup comparison, the 12-month Kaplan–Meier estimates were 72.97% for RFCA and 85.53% for CBA (95% CIs 53.09%–85.48% and 71.98%–92.84%, respectively; log-rank P = 0.220); complication rates were 4/35 (11.43%) and 3/54 (5.56%), respectively (P = 0.427). Conclusion In this single-center cohort of older patients who were considered suitable for and underwent first catheter ablation for AF, no statistically significant differences were detected in 12-month freedom from documented atrial tachyarrhythmia recurrence or periprocedural complication rates across age groups, or between RFCA and CBA among patients aged 75 years or older. However, the modest sample size and limited number of events reduced precision, and generalizability to the broader population of older patients with AF is uncertain.
Authors
- Yibo Ma (ORCID: https://orcid.org/0000-0002-7941-4147)
- Huani Pang
- Miaoyang Hu
- Dong Zhang (ORCID: https://orcid.org/0000-0001-5979-6179)
- Jie Li
- Lejin Luo
- Fu Yi
- Chong Huang
- Yi Wang
- Hui Du
Institutions
- China XD Group (China) (CN)
- Chinese People 's Liberation Army No. 85 Hospital (CN)
- Xijing Hospital (CN)
- Chinese People's Liberation Army (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1186/s12872-026-06947-7
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China